117 related articles for article (PubMed ID: 21987443)
21. Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.
Hertel CB; Zhou XG; Hamilton-Dutoit SJ; Junker S
Oncogene; 2002 Jul; 21(32):4908-20. PubMed ID: 12118370
[TBL] [Abstract][Full Text] [Related]
22. MiR-17/106b seed family regulates p21 in Hodgkin's lymphoma.
Gibcus JH; Kroesen BJ; Koster R; Halsema N; de Jong D; de Jong S; Poppema S; Kluiver J; Diepstra A; van den Berg A
J Pathol; 2011 Dec; 225(4):609-17. PubMed ID: 21953646
[TBL] [Abstract][Full Text] [Related]
23. HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3.
Nagel S; Scherr M; Quentmeier H; Kaufmann M; Zaborski M; Drexler HG; MacLeod RA
Leukemia; 2005 May; 19(5):841-6. PubMed ID: 15772702
[TBL] [Abstract][Full Text] [Related]
24. Chromothripsis in Hodgkin lymphoma.
Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
Genes Chromosomes Cancer; 2013 Aug; 52(8):741-7. PubMed ID: 23630094
[TBL] [Abstract][Full Text] [Related]
25. Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition.
Renné C; Martín-Subero JI; Hansmann ML; Siebert R
J Mol Diagn; 2005 Aug; 7(3):352-6. PubMed ID: 16049307
[TBL] [Abstract][Full Text] [Related]
26. Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells.
Alvaro T; Lejeune M; García JF; Salvadó MT; López C; Bosch R; Jaén J; Escrivá P; Pons LE
Clin Cancer Res; 2008 Feb; 14(3):685-91. PubMed ID: 18245527
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas.
Drakos E; Rassidakis GZ; Leventaki V; Guo W; Medeiros LJ; Nagarajan L
Hum Pathol; 2007 Mar; 38(3):500-7. PubMed ID: 17303500
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
29. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
[TBL] [Abstract][Full Text] [Related]
30. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
31. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
[TBL] [Abstract][Full Text] [Related]
32. U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
Mader A; Bruderlein S; Wegener S; Melzner I; Popov S; Muller-Hermelink HK; Barth TF; Viardot A; Moller P
Cytogenet Genome Res; 2007; 119(3-4):204-10. PubMed ID: 18253030
[TBL] [Abstract][Full Text] [Related]
33. A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma.
Wang HY; Bossler AD; Schaffer A; Tomczak E; DiPatri D; Frank DM; Nowell PC; Bagg A
Cancer Genet Cytogenet; 2007 Jan; 172(1):45-53. PubMed ID: 17175379
[TBL] [Abstract][Full Text] [Related]
34. Classical Hodgkin lymphoma is associated with frequent gains of 17q.
Chui DT; Hammond D; Baird M; Shield L; Jackson R; Jarrett RF
Genes Chromosomes Cancer; 2003 Oct; 38(2):126-36. PubMed ID: 12939740
[TBL] [Abstract][Full Text] [Related]
35. The t(2;3)(q21;q27) translocation in non-Hodgkin's lymphoma displays BCL6 mutations in the 5' regulatory region and chromosomal breakpoints distant from the gene.
Chen W; Butler M; Rao PH; Chaganti SR; Louie DC; Dalla-Favera R; Chaganti RS
Oncogene; 1998 Oct; 17(13):1717-22. PubMed ID: 9796700
[TBL] [Abstract][Full Text] [Related]
36. A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4.
Kawamata N; Sakajiri S; Sugimoto KJ; Isobe Y; Kobayashi H; Oshimi K
Oncogene; 2002 Jul; 21(32):4983-91. PubMed ID: 12118377
[TBL] [Abstract][Full Text] [Related]
37. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression.
Nanjangud G; Rao PH; Teruya-Feldstein J; Donnelly G; Qin J; Mehra S; Jhanwar SC; Zelenetz AD; Chaganti RS
Cytogenet Genome Res; 2007; 118(2-4):337-44. PubMed ID: 18000388
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1.
Nagel S; Burek C; Venturini L; Scherr M; Quentmeier H; Meyer C; Rosenwald A; Drexler HG; MacLeod RA
Blood; 2007 Apr; 109(7):3015-23. PubMed ID: 17148583
[TBL] [Abstract][Full Text] [Related]
39. Molecular karyotypes of Hodgkin and Reed-Sternberg cells at disease onset reveal distinct copy number alterations in chemosensitive versus refractory Hodgkin lymphoma.
Slovak ML; Bedell V; Hsu YH; Estrine DB; Nowak NJ; Delioukina ML; Weiss LM; Smith DD; Forman SJ
Clin Cancer Res; 2011 May; 17(10):3443-54. PubMed ID: 21385932
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A.
Arozarena I; Sanchez-Laorden B; Packer L; Hidalgo-Carcedo C; Hayward R; Viros A; Sahai E; Marais R
Cancer Cell; 2011 Jan; 19(1):45-57. PubMed ID: 21215707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
